KURIYEL RALF
Insider CIK 1733143 · RGEN Senior VP, R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGEN REPLIGEN CORP | A Award deriv | 2026-03-05 | 2026-03-23 | 5,669 | — | $0 | 5,669 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2026-03-05 | 2026-03-23 | 5,284 | — | $0 | 20,062 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-03-04 | 2026-03-05 | 42 | $125.84 | $5.3K | 14,778 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2026-03-04 | 2026-03-05 | 125 | — | $0 | 14,820 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-03-02 | 2026-03-03 | 923 | $124.97 | $115.3K | 14,695 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-02-27 | 2026-03-03 | 444 | $128.73 | $57.2K | 15,618 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2025-03-03 | 2025-03-04 | 4,542 | — | $0 | 4,542 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-03-03 | 2025-03-04 | 386 | $155.38 | $60.0K | 16,062 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2025-03-03 | 2025-03-04 | 4,826 | — | $0 | 16,448 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-02-27 | 2025-02-28 | 391 | $156.54 | $61.2K | 11,622 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-02-24 | 2025-02-25 | 275 | $164.74 | $45.3K | 12,013 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2024-08-02 | 2024-08-05 | 175 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-08-02 | 2024-08-05 | 175 | $158.85 | $27.8K | 12,288 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2024-08-02 | 2024-08-05 | 175 | $86.10 | $15.1K | 12,463 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-08-02 | 2024-08-05 | 6,973 | $159.36 | $1.11M | 12,288 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-08-01 | 2024-08-01 | 4,465 | $165.67 | $739.7K | 19,261 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-05-14 | 2024-05-15 | 534 | $163.34 | $87.2K | 23,726 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2024-03-11 | 2024-03-12 | 1,271 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2024-03-11 | 2024-03-12 | 1,271 | $86.10 | $109.4K | 27,777 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-11 | 2024-03-12 | 3,517 | $193.73 | $681.3K | 24,260 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-03-07 | 2024-03-07 | 386 | $195.72 | $75.5K | 26,506 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-03-04 | 2024-03-06 | 135 | $193.99 | $26.2K | 26,892 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-03-01 | 2024-03-04 | 453 | $191.79 | $86.9K | 27,027 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2024-02-29 | 2024-03-04 | 404 | — | $0 | 27,480 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2024-02-27 | 2024-02-29 | 3,497 | — | $0 | 3,497 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2024-02-27 | 2024-02-29 | 3,520 | — | $0 | 27,076 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2023-05-16 | 2023-05-16 | 710 | $154.03 | $109.4K | 23,556 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2023-03-03 | 2023-03-06 | 3,591 | — | $0 | 25,513 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2023-03-03 | 2023-03-06 | 1,247 | $188.00 | $234.4K | 24,266 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2023-03-02 | 2023-03-06 | 3,591 | — | $0 | 3,591 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2023-03-02 | 2023-03-06 | 3,468 | — | $0 | 21,922 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2023-02-28 | 2023-02-28 | 458 | $173.44 | $79.4K | 18,812 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2023-02-28 | 2023-03-01 | 358 | $173.28 | $62.0K | 18,454 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2022-08-11 | 2022-08-12 | 1,354 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2022-08-11 | 2022-08-12 | 646 | — | $0 | 400 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2022-08-11 | 2022-08-12 | 2,000 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2022-08-11 | 2022-08-12 | 2,000 | $33.05 | $66.1K | 22,110 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2022-08-11 | 2022-08-12 | 646 | $86.10 | $55.6K | 24,110 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-08-11 | 2022-08-12 | 800 | $255.20 | $204.2K | 23,310 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-08-11 | 2022-08-12 | 4,040 | $254.14 | $1.03M | 19,270 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2022-08-11 | 2022-08-12 | 1,354 | $59.52 | $80.6K | 23,464 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-05-13 | 2022-05-17 | 712 | $150.40 | $107.1K | 20,110 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-28 | 2022-03-02 | 473 | $196.70 | $93.0K | 18,172 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2022-02-28 | 2022-03-02 | 4,234 | — | $0 | 22,406 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-28 | 2022-03-02 | 1,584 | $196.70 | $311.6K | 20,822 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-27 | 2022-03-02 | 477 | $196.70 | $93.8K | 18,645 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2022-02-24 | 2022-02-28 | 2,723 | — | $0 | 2,723 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-24 | 2022-02-28 | 188 | $189.21 | $35.6K | 19,122 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2022-02-24 | 2022-02-28 | 2,126 | — | $0 | 19,310 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-17 | 2022-02-22 | 175 | $182.42 | $31.9K | 17,184 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2022-02-17 | 2022-02-22 | 450 | — | $0 | 17,359 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2021-12-14 | 2021-12-15 | 445 | $252.53 | $112.4K | 16,909 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-30 | 2021-09-02 | 4,001 | $282.13 | $1.13M | 17,354 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-06-10 | 2021-06-14 | 1,045 | — | $0 | 2,092 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-06-10 | 2021-06-14 | 2,557 | — | $0 | 1,354 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-06-10 | 2021-06-14 | 6,802 | $189.19 | $1.29M | 21,355 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-06-10 | 2021-06-14 | 2,557 | $59.52 | $152.2K | 27,112 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-06-10 | 2021-06-14 | 1,045 | $86.10 | $90.0K | 28,157 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-14 | 2021-05-18 | 710 | $172.29 | $122.3K | 24,555 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-03-10 | 2021-03-12 | 150 | — | $0 | 3,911 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-03-10 | 2021-03-12 | 2,000 | — | $0 | 2,000 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-03-10 | 2021-03-12 | 5,850 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-03-10 | 2021-03-12 | 150 | $59.52 | $8.9K | 33,265 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-10 | 2021-03-12 | 1,004 | $192.13 | $192.9K | 25,265 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-03-10 | 2021-03-12 | 2,000 | $33.05 | $66.1K | 27,265 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-10 | 2021-03-12 | 6,354 | $190.08 | $1.21M | 26,911 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-10 | 2021-03-12 | 642 | $191.33 | $122.8K | 26,269 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-03-10 | 2021-03-12 | 5,850 | $33.87 | $198.1K | 33,115 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 25 | $194.30 | $4.9K | 26,915 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 400 | $196.23 | $78.5K | 26,940 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 350 | $192.24 | $67.3K | 26,565 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 600 | $191.20 | $114.7K | 25,965 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 700 | $190.06 | $133.0K | 25,265 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2021-02-24 | 2021-02-26 | 2,035 | — | $0 | 2,035 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2021-02-24 | 2021-02-26 | 1,686 | — | $0 | 27,340 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-12-16 | 2020-12-18 | 435 | $186.18 | $81.0K | 25,654 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-08-06 | 2020-08-10 | 5,000 | — | $0 | 5,850 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-08-06 | 2020-08-10 | 5,000 | $153.79 | $769.0K | 26,089 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-08-06 | 2020-08-10 | 5,000 | $33.87 | $169.3K | 31,089 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-15 | 2020-05-19 | 435 | $140.69 | $61.2K | 26,089 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-05-13 | 2020-05-15 | 6,000 | — | $0 | 4,000 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-05-13 | 2020-05-15 | 2,000 | — | $0 | 10,850 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-13 | 2020-05-15 | 6,293 | $128.02 | $805.6K | 26,619 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-05-13 | 2020-05-15 | 6,000 | $33.05 | $198.3K | 32,524 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-05-13 | 2020-05-15 | 2,000 | $33.87 | $67.7K | 34,524 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-13 | 2020-05-15 | 1,612 | $126.88 | $204.5K | 32,912 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-13 | 2020-05-15 | 95 | $128.55 | $12.2K | 26,524 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-04 | 2020-03-05 | 1,905 | $90.99 | $173.3K | 26,524 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-04 | 2020-03-05 | 650 | $90.08 | $58.6K | 28,429 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-03 | 2020-03-05 | 450 | $88.35 | $39.8K | 29,079 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2020-02-27 | 2020-03-02 | 3,137 | — | $0 | 3,137 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2020-02-27 | 2020-03-02 | 3,216 | — | $0 | 29,529 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-26 | 2020-02-27 | 195 | $86.60 | $16.9K | 26,313 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2019-12-16 | 2019-12-18 | 295 | $90.43 | $26.7K | 26,508 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2019-05-13 | 2019-05-15 | 8,000 | — | $0 | 26,803 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-03-05 | 2019-03-05 | 2,240 | $58.53 | $131.1K | 18,803 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2019-03-01 | 2019-03-05 | 4,700 | — | $0 | 21,043 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2019-02-28 | 2019-06-11 | 4,061 | — | $0 | 4,061 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2019-02-28 | 2019-03-04 | 4,042 | — | $0 | 4,042 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-02-28 | 2019-03-04 | 185 | $59.16 | $10.9K | 16,343 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2019-02-28 | 2019-03-04 | 4,234 | — | $0 | 16,528 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2018-12-18 | 2018-12-20 | 311 | $54.44 | $16.9K | 12,294 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2018-03-01 | 2018-03-05 | 12,850 | — | $0 | 12,850 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2018-03-01 | 2018-03-05 | 6,643 | — | $0 | 12,605 | SEC↗ |